Market closedADR
GSK/$GSK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GSK
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Ticker
$GSK
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Employees
68,629
Website
GSK Metrics
BasicAdvanced
$79B
48.13
$0.80
0.29
$1.53
4.06%
Price and volume
Market cap
$79B
Beta
0.29
52-week high
$45.93
52-week low
$31.72
Average daily volume
5.1M
Dividend rate
$1.53
Financial strength
Current ratio
0.783
Quick ratio
0.517
Long term debt to equity
111.852
Total debt to equity
129.803
Dividend payout ratio (TTM)
94.91%
Interest coverage (TTM)
9.82%
Management effectiveness
Return on assets (TTM)
6.52%
Return on equity (TTM)
22.80%
Valuation
Price to earnings (TTM)
48.128
Price to revenue (TTM)
3.89
Price to book
4.44
Price to tangible book (TTM)
-6.88
Price to free cash flow (TTM)
32.959
Dividend yield (TTM)
3.95%
Forward dividend yield
4.06%
Growth
Revenue change (TTM)
3.46%
Earnings per share change (TTM)
-48.12%
3-year revenue growth (CAGR)
8.31%
3-year earnings per share growth (CAGR)
-16.85%
3-year dividend per share growth (CAGR)
-15.19%
What the Analysts think about GSK
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for GSK stock.
GSK Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
GSK Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
GSK News
AllArticlesVideos
April 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against GSK
Accesswire·2 hours ago
GSK DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action - GSK
Accesswire·2 hours ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK plc Lawsuit - GSK
Accesswire·4 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closedADR
Upcoming events
Apr10
GSK
Dividend·Payment
$0.400652
Per share
FAQs
What’s the current market cap for GSK stock?
GSK (GSK) has a market cap of $79B as of April 01, 2025.
What is the P/E ratio for GSK stock?
The price to earnings (P/E) ratio for GSK (GSK) stock is 48.13 as of April 01, 2025.
Does GSK stock pay dividends?
Yes, the GSK (GSK) stock pays dividends to shareholders. As of April 01, 2025, the dividend rate is $1.52889 and the yield is 4.06%. GSK has a payout ratio of 94.91% on a trailing twelve-month basis.
When is the next GSK dividend payment date?
The next GSK (GSK) dividend payment is scheduled for April 10, 2025.
What is the beta indicator for GSK?
GSK (GSK) has a beta rating of 0.29. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.